Pre-publish vs post-publish: why the sequence matters for Australian health marketing compliance

The TGA Advertising Code 2021 places the compliance obligation on the advertiser at the point of publication. Under s.5 of the Code, an advertisement must comply with all applicable requirements at the time it is published, broadcast, or distributed. The obligation is not contingent on whether a complaint has been received or a scan has been run.

This has a practical consequence: the moment non-compliant content goes live, the enforcement clock starts. The TGA's investigation process — complaint, assessment, removal request, infringement notice — is triggered by publication, not by discovery. A brand that publishes non-compliant content on Monday and identifies it through a post-publish scan on Friday has carried four days of enforcement exposure. The infringement notice risk does not pause while the scan is pending.

The AHPRA Advertising Guidelines make the same point differently. Under the Guidelines, a health practitioner is responsible for advertising content published about their practice — including content published by a third party on their behalf. The compliance obligation exists from the moment content is published. Post-publication discovery does not extinguish the obligation that existed at publication.

When non-compliant content is published, three things happen simultaneously:

• 1. The enforcement window opens. The TGA, AHPRA, and ACCC can receive complaints from the moment content is publicly accessible. In 2023–24, the TGA received 3,370 advertising reports and issued 4,806 removal requests — an average of more than 13 removal requests per day. Complaints can be filed the day content is published. AHPRA assessed 775 advertising complaints in 2024–25, up 104% over two years.
• 2. The audit trail problem begins. If content has been live for days or weeks before a compliance issue is identified, the brand has no contemporaneous evidence of a pre-publication review. Regulators consider evidence of a compliance process when assessing whether to issue an infringement notice. A documented pre-publish review is evidence of due diligence. A post-publish scan identifying a problem after the fact is evidence of remediation — which is valuable, but it is not the same as prior diligence.
• 3. Commercial exposure accumulates. Non-compliant advertising generates impressions, clicks, and potentially sales while the enforcement window is open. If a product makes a prohibited claim, any sale made while that claim was live creates potential liability exposure beyond the advertising infringement itself.

Post-publish compliance scanning serves a genuine purpose. For brands with large volumes of existing published content — product pages, blog archives, social media histories — scanning identifies what is already live and non-compliant. This is valuable remediation work. It closes past enforcement windows.

What post-publish scanning does not do:

• It does not prevent the enforcement window from opening in the first place. A scan run after a product launch identifies problems that already existed in the market during the window between publication and scan completion. For a brand publishing three social posts per week, that window recurs weekly.
• It does not create a pre-publication audit record. A scan report dated after content was published shows when a problem was found, not that a compliance process was completed before publication. These are different evidence positions in a regulatory investigation.
• It does not address content that moves faster than the scan cycle. Social media content, email campaigns, and influencer posts can reach audiences immediately after publication. If a scan cycle is weekly or monthly, non-compliant content can complete its full distribution window before the scan identifies the issue.

For brands managing compliance across TGA, AHPRA, FSANZ, and ACCC — four distinct regulatory frameworks with different requirements for different content types — the volume of publishing activity typically outpaces what a reactive scan cycle can effectively govern.

CompliGUARD is compliance infrastructure, not a post-publication scanner. Each piece of content is submitted before it is published and assessed against TGA, AHPRA, FSANZ, and ACCC requirements in a single review. The output is a structured compliance report with a risk rating by framework, specific flagged issues referenced to clause, rewrite suggestions, and a retained audit record.

The workflow: draft → submit to CompliGUARD → receive compliance report → revise if required → publish with documented prior review.

The audit record created at the pre-publish stage is contemporaneous evidence of a compliance process. It exists before the enforcement window opens. This is the practical difference between pre-publish compliance infrastructure and post-publish scanning.

For health brands managing repeat publishing across social, email, and product pages, pre-publish review scales with volume: each new piece of content generates its own report and audit record before it reaches the market.

CompliGUARD provides compliance insights based on TGA, FSANZ, ACCC and AHPRA guidance current at the time of review. The Therapeutic Goods Advertising Code is under formal review by the TGA (2025–26). This content does not constitute legal advice.

• Publishing without checking the complete advertisement’s overall impression.
• Treating one regulator’s checklist as coverage for every applicable framework.
• Failing to retain evidence showing what was reviewed and approved before publication.

CompliGUARD reviews the complete advertisement against TGA · AHPRA · FSANZ · ACCC requirements, identifies clause-level risks, proposes compliant wording, and retains the result in an audit trail before publication.